Case Western, Sangamo awarded grant to advance research on gene-edited T cells to treat HIV Feb. 8, 2018
American Gene Technologies makes progress towards phase I study of HIV functional cure product Jan. 29, 2018
Merck Sharp & Dohme initiates phase I study of MK-4250 in ART-naive patients with HIV-1 Jan. 29, 2018